Meridian Bioscience beats by $0.04, beats on revenue

|About: Meridian Bioscience Inc. (VIVO)|By:, SA News Editor

Meridian Bioscience (NASDAQ:VIVO): Q4 Non-GAAP EPS of $0.20 beats by $0.04; GAAP EPS of $0.13 misses by $0.02.

Revenue of $53.1M (+6.8% Y/Y) beats by $1.99M.

Press Release

Subscribe for full text news in your inbox